Cutting-Edge 3D-Printed Microneedle Technology Revolutionizes Drug Delivery and Diagnostics
By HospiMedica International staff writers Posted on 08 Aug 2024 |

A groundbreaking system that integrates remote health monitoring and drug delivery using 3D-printed hollow microneedles is set to revolutionize healthcare, particularly benefiting those in underserved or remote areas.
Developed by researchers at the University of Victoria (Victoria, BC, Canada) and the Terasaki Institute for Biomedical Innovation (TIBI, Los Angeles, CA, USA), this integrated theranostic microneedle array (MNA) system marks a significant step forward in personalized medicine. The system's 3D-printed hollow microneedles enable painless and minimally invasive access to interstitial fluid, transforming both drug delivery and diagnostics. It includes an array of colorimetric sensors capable of quantitatively measuring vital health indicators such as pH, glucose, and lactate levels, while also featuring a remotely-triggered mechanism for on-demand drug delivery. Notably, the system employs an ultrasonic atomizer that simplifies the drug delivery process. This innovation, detailed in a publication in Advanced Healthcare Materials, facilitates rapid, pumpless, point-of-care drug administration, enhancing the system's portability and simplicity.
The system has extensive capabilities, demonstrating the ability to monitor pH levels from 3 to 8, glucose up to 16 mm, and lactate up to 1.6 mm. These metrics are essential for tracking various health conditions. A key aspect of this technology is its smartphone application, which acts as an interface for both sensing and drug delivery operations. This user-friendly platform allows patients and healthcare providers to easily manage and interpret data and oversee the drug delivery process. The broader implications of this technology are profound. It offers a means to extend remote health monitoring and treatment capabilities, potentially overcoming geographical and socioeconomic barriers in healthcare access. This democratization of healthcare resources could lead to timelier medical interventions, ongoing health condition monitoring, and genuinely personalized care, regardless of a patient's location or financial status.
The potential of this system to improve the management of chronic diseases, which often require sustained treatment regimens, is particularly promising. Its capacity for on-demand medication delivery and non-invasive health monitoring could significantly enhance patient outcomes and quality of life. As global healthcare systems face challenges related to equity and accessibility, this technology presents a vision for a future where high-quality healthcare is not confined by geographical or economic limitations. The system represents a substantial advancement in merging remote monitoring, on-demand drug delivery, and accessible user interfaces, paving the way toward more equitable health outcomes and resource distribution. The developers of this innovative system have effectively tackled existing challenges in drug delivery and health monitoring, setting the stage for ongoing innovations in personalized, accessible healthcare for all.
"This innovative approach confronts drug delivery challenges, particularly in managing chronic diseases requiring long-term treatment, while also offering avenues for non-invasive health monitoring through microneedle-based sensors," said Dr. Ali Khademhosseini, CEO of TIBI and a renowned expert in bioengineering.
Related Links:
University of Victoria
TIBI
Latest Critical Care News
- Novel Coating Significantly Extends Longevity of Implantable Biosensors
- Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
- New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
- Battery-Powered Wearable Device Monitors Joint Pain
- Wireless Pacifier Monitors Vitals of NICU Babies Without Need for Painful Blood Draws
- Breakthrough Sensor Technology Tracks Stroke After Effects
- New Study Demonstrates AI-Assisted Detection of Reduced Ejection Fraction
- Novel 3D Adipose Tissue Bioprinting Method to Find Applications in Regenerative Medicine
- Miniaturized Pacemaker for Newborns Found Safe and Effective for Up to Two Years
- World’s First 3D Neural Electrode Uses Soft Actuation Technology to Avoid Nerve Damage
- Smartwatch Algorithm Detects Cardiac Arrest
- Blood-Brain Barrier “Organ Chip” Treats Brain Tumors Unreachable by Chemotherapy
- AI Model Could Use ECG Tests to Detect Premature Aging and Cognitive Decline
- World-First Technology Uses Real-Time ECG Signal Analysis for Accurate CVAD Placement
- AI Outperforms Humans at Analyzing Long-Term ECG Recordings
- Smart Sensor Enables Precise, Self-Powered Tracking of Healing Wounds
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more